7 Tesla MR spectroscopy in diffusely infiltrating gliomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003306

Enrollment

Registered

2011-10-18

Start date

2012-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9

Interventions

Group 1: Proton magnetic resonance spectroscopic imaging at 7 Tesla in brain tumor patients (glioma) Group 2: Proton magnetic resonance spectroscopic imaging at 7 Tesla in healthy subjects

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: -(in case of patients) radiologically verified brain tumor (diffus infiltrating glioma, WHO grade II-IV) -(in case of patients) adequate performance score (Karnofsky score >70%)

Exclusion criteria

Exclusion criteria: -pregnancy -any contraindications for MR imaging -pacemaker -(in case of volunteers) disease of the central nervous system (especially the brain)

Design outcomes

Primary

Measure	Time frame
Development of an improved magnetic resonance spectroscopy sequence for 7 Tesla for three-dimensional metabolic mapping of pathologic brain areas.	—

Secondary

Measure	Time frame
Successful clinical evaluation of developed 7 Tesla magnetic resonance spectroscopy method on brain tumor patients in comparison to healthy controls.	—

Countries

Austria

Contacts

Public ContactWolfgang Bogner

MR Exzellenzzentrum, Universitätsklinik für Radiodiagnostik, Medizinische Universität Wien

wolfgang.bogner@meduniwien.ac.at+43 1 40400 6471

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026